Skip to main content

Riabni

Generic: rituximab-arrx

Verified·Oct 26, 2026
Manufacturer
Amgen
NDC
55513-224
RxCUI
2472327
Route
INTRAVENOUS
ICD-10 indication
C85.90

Affordability Check

How much will you actually pay for Riabni?

In 30 seconds, see every legitimate way to afford Riabni — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Riabni

What is this medication?

Riabni is a prescription biological medication classified as a monoclonal antibody that serves as a biosimilar to Rituxan. It works by targeting and attaching to a specific protein called CD20, which is found on the surface of B-lymphocytes, a type of white blood cell. By binding to these cells, the medication helps the immune system recognize and destroy them, which is helpful in treating diseases where these cells grow uncontrollably or mistakenly attack the body's own tissues.

This medication is used to treat several different conditions in adults, including certain types of cancer like non-Hodgkin lymphoma and chronic lymphocytic leukemia. It is also approved for the treatment of various autoimmune and inflammatory disorders, such as rheumatoid arthritis in patients who have not responded well to other therapies. Furthermore, Riabni is used for specific types of blood vessel inflammation known as granulomatosis with polyangiitis and microscopic polyangiitis.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Not Publicly Available
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

Riabni treats 5 rare conditions. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.